Perspective Therapeutics Future Growth
Future criteria checks 0/6
Perspective Therapeutics's revenue and earnings are forecast to decline at 100% and 12.4% per annum respectively while EPS is expected to decline by 7.3% per annum.
Key information
-12.4%
Earnings growth rate
-7.3%
EPS growth rate
Biotechs earnings growth | 21.3% |
Revenue growth rate | -100.0% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 09 Apr 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | N/A | -63 | 88 | N/A | 1 |
12/31/2025 | N/A | -56 | -54 | N/A | 2 |
12/31/2024 | N/A | -48 | -52 | N/A | 2 |
12/31/2023 | 1 | -37 | -38 | -37 | N/A |
9/30/2023 | 6 | -29 | -35 | -34 | N/A |
6/30/2023 | 6 | -23 | -27 | -26 | N/A |
3/31/2023 | 6 | -14 | -21 | -20 | N/A |
12/31/2022 | 5 | -8 | -11 | -10 | N/A |
9/30/2022 | 10 | -9 | -8 | -7 | N/A |
6/30/2022 | N/A | -6 | -8 | -8 | N/A |
3/31/2022 | 11 | -6 | -6 | -6 | N/A |
12/31/2021 | 11 | -6 | -5 | -5 | N/A |
9/30/2021 | 10 | -5 | -5 | -5 | N/A |
6/30/2021 | 10 | -3 | -3 | -3 | N/A |
3/31/2021 | 10 | -4 | -3 | -3 | N/A |
12/31/2020 | 10 | -3 | -3 | -3 | N/A |
9/30/2020 | 10 | -3 | -4 | -3 | N/A |
6/30/2020 | 10 | -3 | -4 | -4 | N/A |
3/31/2020 | 9 | -3 | -4 | -4 | N/A |
12/31/2019 | 8 | -4 | -5 | -4 | N/A |
9/30/2019 | 8 | -4 | -5 | -4 | N/A |
6/30/2019 | 7 | -5 | -5 | -5 | N/A |
3/31/2019 | 7 | -6 | -6 | -6 | N/A |
12/31/2018 | 7 | -7 | -6 | -5 | N/A |
9/30/2018 | 6 | -7 | -6 | -6 | N/A |
6/30/2018 | 6 | -7 | -6 | -6 | N/A |
3/31/2018 | 6 | -6 | -6 | -5 | N/A |
12/31/2017 | 5 | -6 | -6 | -6 | N/A |
9/30/2017 | 5 | -6 | N/A | -6 | N/A |
6/30/2017 | 5 | -6 | N/A | -6 | N/A |
3/31/2017 | 5 | -6 | N/A | -6 | N/A |
12/31/2016 | 4 | -5 | N/A | -5 | N/A |
9/30/2016 | 5 | -5 | N/A | -4 | N/A |
6/30/2016 | 5 | -5 | N/A | -4 | N/A |
3/31/2016 | 5 | -5 | N/A | -3 | N/A |
12/31/2015 | 5 | -4 | N/A | -4 | N/A |
9/30/2015 | 5 | -4 | N/A | -3 | N/A |
6/30/2015 | 5 | -4 | N/A | -4 | N/A |
3/31/2015 | 4 | -4 | N/A | -4 | N/A |
12/31/2014 | 4 | -5 | N/A | -3 | N/A |
9/30/2014 | 4 | -5 | N/A | -3 | N/A |
6/30/2014 | 4 | -7 | N/A | -3 | N/A |
3/31/2014 | 4 | -6 | N/A | -3 | N/A |
12/31/2013 | 5 | -5 | N/A | -3 | N/A |
9/30/2013 | 4 | -5 | N/A | -3 | N/A |
6/30/2013 | 5 | -4 | N/A | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CATX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: CATX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: CATX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: CATX is forecast to have no revenue next year.
High Growth Revenue: CATX is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CATX's Return on Equity is forecast to be high in 3 years time